Shall we include US findings in CASPAR criteria? ⚡️ Adding US tenosynovitis and/or enthesitis - improves Specificity 91% vs. 68% -while maintaining sensitivity 92% vs. 96% #EULAR2022 @RheumNow POS0315 https://t.co/kuxPpVEQng